Last 12 months
Inside the activity.
4 purchase rows · 28 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 3 | 3 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 1 | 4 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 8 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 27, 2016 Filed Oct 28, 2016 16:17 UTC |
de Pesquidoux HubertDirector
|
GrantNon-employee Warrant (right to buy) · Derivative | 13,185 | $0.00 Strike: $36.92 | $0.00 |
DisclosureSEC source: 0001576427-16-000382 · wf-form4_147768584935680.xml · derivative · entry 1 de Pesquidoux Hubert · CIK 0001464176 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,185 Underlying: Ordinary Shares · 13,185 shares Expires 2026-10-27 F1 · derivative.exercise_price: The exercise price of the non-employee warrant is 33.98 euros. The U.S. dollar equivalent of the exercise price is $36.92 using the Federal Reserve Bank of New York noon buying rate for October 21, 2016 (1.00 = $1.0866). F2 · derivative.exercise_date: One-fourth of the grant will vest on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter. F3 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| October 27, 2016 Filed Oct 28, 2016 20:12 UTC |
EVAN DANA LDirector
|
GrantNon-employee Warrant (right to buy) · Derivative | 13,185 | $0.00 Strike: $36.92 | $0.00 |
DisclosureSEC source: 0001576427-16-000378 · wf-form4_147768550658129.xml · derivative · entry 1 EVAN DANA L · CIK 0001204818 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,185 Underlying: Ordinary Shares · 13,185 shares Expires 2026-10-27 F1 · derivative.exercise_price: The exercise price of the non-employee warrant is 33.98 euros. The U.S. dollar equivalent of the exercise price is $36.92 using the Federal Reserve Bank of New York noon buying rate for October 21, 2016 (1.00 = $1.0866) F2 · derivative.exercise_date: One-fourth of the grant will vest on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter. F3 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| October 27, 2016 Filed Oct 28, 2016 16:14 UTC |
WARNER JAMESDirector
|
GrantNon-employee Warrant (right to buy) · Derivative | 13,185 | $0.00 Strike: $36.92 | $0.00 |
DisclosureSEC source: 0001576427-16-000380 · wf-form4_147768565756566.xml · derivative · entry 1 WARNER JAMES · CIK 0001193080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,185 Underlying: Ordinary Shares · 13,185 shares Expires 2026-10-27 F1 · derivative.exercise_price: The exercise price of the non-employee warrant is 33.98 euros. The U.S. dollar equivalent of the exercise price is $36.92 using the Federal Reserve Bank of New York noon buying rate for October 21, 2016 (1.00 = $1.0866) F2 · derivative.exercise_date: One-fourth of the grant will vest on the first anniversary of the grant date and an additional 1/16th of the grant vests quarterly thereafter. F3 · derivative.underlying: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. Read SEC document |
| October 04, 2016 Filed Oct 5, 2016 20:19 UTC |
Rudelle Jean-BaptisteDirector · Executive Chairman
|
SaleOrdinary Shares | 10,873 | $36.09 | $392,406.57 |
DisclosureSEC source: 0001576427-16-000375 · wf-form4_147569873108907.xml · nonDerivative · entry 2 Rudelle Jean-Baptiste · CIK 0001599373 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,795,958 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan (the "Trading Plan") adopted by the reporting person. The sales are made in accordance with a trading schedule that is established at the time the Trading Plan is put in place. The reporting person entered into the Trading Plan during an open trading window of the issuer pursuant to its Insider Trading Policy. F4 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.67 to $36.55, inclusive. Read SEC document |
| October 03, 2016 Filed Oct 5, 2016 20:19 UTC |
Rudelle Jean-BaptisteDirector · Executive Chairman
|
SaleOrdinary Shares | 49,127 | $35.78 | $1,757,764.06 |
DisclosureSEC source: 0001576427-16-000375 · wf-form4_147569873108907.xml · nonDerivative · entry 1 Rudelle Jean-Baptiste · CIK 0001599373 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,806,831 F1 · security: The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan (the "Trading Plan") adopted by the reporting person. The sales are made in accordance with a trading schedule that is established at the time the Trading Plan is put in place. The reporting person entered into the Trading Plan during an open trading window of the issuer pursuant to its Insider Trading Policy. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $35.14 to $36.09, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnote (4) to this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.